Transcriptional signature induced by a metastasis-promoting c-Src mutant in a human breast cell line

Felix Broecker1,2, Christopher Hardt1, Ralf Herwig1

  • 1Max Planck Institute for Molecular Genetics, Berlin, Germany.

The FEBS Journal
|February 27, 2016
PubMed
Abstract

Insights

Constitutively active c-Src kinase mutants promote cell migration and metastasis. This study identifies key genes and pathways altered by these mutants, offering potential therapeutic targets for cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Deletions in the C-terminus of c-Src kinase are linked to increased activity and invasiveness in viral oncogenes and some human cancers.
  • Constitutively active c-Src mutants (c-Src(mt)) are known to alter cell migration and metastasis.

Purpose of the Study:

  • To analyze the mRNA expression signature of a constitutively active C-terminal mutant of c-Src (c-Src(mt)) in MCF-10A cells.
  • To identify transcriptional changes associated with an invasive cellular phenotype induced by c-Src(mt).

Main Methods:

  • Genome-wide transcriptome analysis (RNA-Seq) of MCF-10A cells expressing c-Src(mt) versus wild-type c-Src (c-Src(wt)).
  • In vivo metastasis assay in mice to assess the metastatic capacity of cells expressing c-Src(mt).

Main Results:

  • c-Src(mt) de-regulated approximately 430 mRNAs involved in migration, adhesion, apoptosis, and protein synthesis.
  • 82.9% of the de-regulated genes were previously linked to cellular migration.
  • Cells expressing c-Src(mt) demonstrated metastatic capacity in vivo, unlike those with c-Src(wt).
  • The mRNA expression profile of c-Src(mt)-expressing cells showed overlap with primary human tumor samples.

Conclusions:

  • c-Src(mt) expression elevates migratory potential and drives an invasive cellular phenotype.
  • The identified genes and pathways de-regulated by c-Src(mt) represent potential biomarkers or therapeutic targets for metastatic cancers.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.4K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.8K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K